Is medtech held to a double standard on innovation? A conversation with B. Braun’s Caroll Neubauer
October 7, 2014 by Brian Johnson
MassDevice.com catches up with B. Braun Medical CEO Caroll Neubauer to discuss whether medtech is held to a different standard when it comes to innovation.
Do we hold medicine to the same standards as anti-lock brakes, GPS systems and iPhones when it comes to innovation?
That was the subject on the table when MassDevice.com caught up with B. Braun Medical CEO Caroll Neubauer at AdvaMed 2014 in Chicago this week.
Neubauer, who has been with the 175-year-old German medical products maker since 1988, is a major presence at AdvaMed, the medical device industry council, where he is a member of the board of directors. Not surprisingly, Neubauer had strong feelings on the subject of innovation in medtech.
As chairman & CEO of a private company, Neubauer is able to express himself in ways his colleagues at publicly traded companies aren’t free to do, making him 1 of the most outspoken leaders in the medical device industry.
Our chat with Neubauer, transcribed below and edited for clarity, is a preview of a longer conversation we’ll be having with him when he joins MassDevice.com Nov. 19 in Irvine, Calif., forDeviceTalks West.
